World Top 1,000 Companies as of January 2024
World Rank (Jan-05-2024)
15,750
Market Cap (Jan-05-2024)
0.301 Billion USD
World Rank (Jul-30-2023)
15,333
Market Cap (Jul-30-2023)
0.328 Billion USD
World Rank (Dec-25-2022)
14,908
Market Cap (Dec-25-2022)
0.342 Billion USD
World Rank (Jan-05-2024)
15,751
Market Cap (Jan-05-2024)
0.301 Billion USD
World Rank (Jul-30-2023)
15,729
Market Cap (Jul-30-2023)
0.306 Billion USD
World Rank (Dec-25-2022)
16,446
Market Cap (Dec-25-2022)
0.268 Billion USD
World Rank (Jan-07-2022)
16,754
Market Cap (Jan-07-2022)
0.30 Billion USD
World Rank (Jan-05-2024)
15,751
World Rank (Jul-30-2023)
15,751
World Rank (Dec-25-2022)
15,751
World Rank (Jan-07-2022)
15,751
Market Cap (Jan-07-2022)
0.35 Billion USD
World Rank (Jan-05-2024)
15,752
Market Cap (Jan-05-2024)
0.301 Billion USD
World Rank (Jul-30-2023)
16,415
Market Cap (Jul-30-2023)
0.271 Billion USD
World Rank (Dec-25-2022)
15,488
Market Cap (Dec-25-2022)
0.311 Billion USD
World Rank (Jan-07-2022)
17,184
Market Cap (Jan-07-2022)
0.28 Billion USD
Annual Revenue in USD
134 Million USD
Annual Net Income in USD
33 Million USD
Annual Results for Period Ending
Dec-2020 ending year
World Rank (Jan-05-2024)
15,753
Market Cap (Jan-05-2024)
0.301 Billion USD
World Rank (Jul-30-2023)
16,301
Market Cap (Jul-30-2023)
0.277 Billion USD
World Rank (Dec-25-2022)
17,430
Market Cap (Dec-25-2022)
0.223 Billion USD
World Rank (Jan-07-2022)
16,751
Market Cap (Jan-07-2022)
0.30 Billion USD
World Rank (Jan-05-2024)
15,754
Market Cap (Jan-05-2024)
0.301 Billion USD
World Rank (Jul-30-2023)
15,437
Market Cap (Jul-30-2023)
0.323 Billion USD
World Rank (Dec-25-2022)
18,106
Market Cap (Dec-25-2022)
0.196 Billion USD
World Rank (Jan-07-2022)
19,093
Market Cap (Jan-07-2022)
0.20 Billion USD
World Rank (Jan-05-2024)
15,755
World Rank (Jul-30-2023)
15,755
Market Cap (Jul-30-2023)
0.303 Billion USD
World Rank (Dec-25-2022)
15,755
Market Cap (Dec-25-2022)
0.299 Billion USD
World Rank (Jan-07-2022)
14,658
Market Cap (Jan-07-2022)
0.42 Billion USD
Annual Revenue in USD
0 Million USD
Annual Net Income in USD
-71 Million USD
Annual Results for Period Ending
Dec-2020 ending year
Company Profile
Oyster Point Pharma is a Clinical Stage Biopharmaceutical company focused on the discovery, development and commercialization of first in class pharmaceutical therapies to treat ocular surface diseases. The company annual revenue is 16.5 million USD and 62 employees as on 2020. The headquarters is in USA.
World Rank (Jan-05-2024)
15,755
Market Cap (Jan-05-2024)
0.301 Billion USD
World Rank (Jul-30-2023)
15,908
Market Cap (Jul-30-2023)
0.296 Billion USD
World Rank (Dec-25-2022)
15,894
Market Cap (Dec-25-2022)
0.292 Billion USD
World Rank (Jan-07-2022)
14,752
Market Cap (Jan-07-2022)
0.41 Billion USD
Annual Revenue in USD
31 Million USD
Annual Net Income in USD
6 Million USD
Annual Results for Period Ending
Aug-2020 ending year
World Rank (Jan-05-2024)
15,756
Market Cap (Jan-05-2024)
0.301 Billion USD
World Rank (Jul-30-2023)
15,558
Market Cap (Jul-30-2023)
0.316 Billion USD
World Rank (Dec-25-2022)
23,770
Market Cap (Dec-25-2022)
0.066 Billion USD
World Rank (Jan-07-2022)
25,258
Market Cap (Jan-07-2022)
0.07 Billion USD
World Rank (Jan-05-2024)
15,757
Market Cap (Jan-05-2024)
0.301 Billion USD
World Rank (Jul-30-2023)
15,735
Market Cap (Jul-30-2023)
0.305 Billion USD
World Rank (Dec-25-2022)
13,572
Market Cap (Dec-25-2022)
0.420 Billion USD
World Rank (Jan-07-2022)
18,871
Market Cap (Jan-07-2022)
0.21 Billion USD
Annual Revenue in USD
59 Million USD
Annual Net Income in USD
9 Million USD
Annual Results for Period Ending
Dec-2020 ending year